BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 31146741)

  • 1. Prophylactic NS-21 maintains the skin moisture but does not reduce the severity of radiation dermatitis in patients with head and neck cancer: a randomized control trial.
    Chou HL; Shueng PW; Liao LJ; Hsu CX; Kuo DY; Lo WC; Hou PY; Wang LY; Chou SF; Hsieh CH
    Radiat Oncol; 2019 May; 14(1):90. PubMed ID: 31146741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients.
    Ingargiola R; De Santis MC; Iacovelli NA; Facchinetti N; Cavallo A; Ivaldi E; Dispinzieri M; Franceschini M; Giandini C; Romanello DA; Di Biaso S; Sabetti M; Locati L; Alfieri S; Bossi P; Guglielmo M; Macchi F; Lozza L; Valdagni R; Fallai C; Pignoli E; Orlandi E
    Radiat Oncol; 2020 Aug; 15(1):193. PubMed ID: 32791985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Randomized Trial of Mometasone Furoate 0.1% to Reduce High-Grade Acute Radiation Dermatitis in Breast Cancer Patients Receiving Postmastectomy Radiation.
    Ho AY; Olm-Shipman M; Zhang Z; Siu CT; Wilgucki M; Phung A; Arnold BB; Porinchak M; Lacouture M; McCormick B; Powell SN; Gelblum DY
    Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):325-333. PubMed ID: 29726361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter Randomized Double-Blind, Placebo-Controlled Trial GORTEC (Groupe Oncologie Radiotherapie Tete et Cou) 2009-01 Evaluating the Effect of the Regenerating Agent on Radiodermatitis of Head and Neck Cancer Patients.
    Tao Y; Auperin A; Sire C; Martin M; Saliou MG; Bardet E; Sun XS; Chatellier T; Morand C; Cornely A; Angokai M; Di Rito A; Kichenin K; Blanchard P; D'Onofrio I; Bourhis J
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):590-595. PubMed ID: 29280453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preemptive treatment with Xonrid®, a medical device to reduce radiation induced dermatitis in head and neck cancer patients receiving curative treatment: a pilot study.
    Iacovelli NA; Naimo S; Bonfantini F; Cavallo A; Bossi P; Fallai C; Pignoli E; Alfieri S; Bergamini C; Favales F; Orlandi E
    Support Care Cancer; 2017 Jun; 25(6):1787-1795. PubMed ID: 28108819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, self-controlled, prospective assessment of the efficacy of mometasone furoate local application in reducing acute radiation dermatitis in patients with head and neck squamous cell carcinomas.
    Liao Y; Feng G; Dai T; Long F; Tang J; Pu Y; Zheng X; Cao S; Xu S; Du X
    Medicine (Baltimore); 2019 Dec; 98(52):e18230. PubMed ID: 31876704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiotherapy related skin toxicity (RAREST-01): Mepitel® film versus standard care in patients with locally advanced head-and-neck cancer.
    Narvaez C; Doemer C; Idel C; Setter C; Olbrich D; Ujmajuridze Z; Carl JH; Rades D
    BMC Cancer; 2018 Feb; 18(1):197. PubMed ID: 29454311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial).
    Robijns J; Lodewijckx J; Claes S; Van Bever L; Pannekoeke L; Censabella S; Bussé L; Colson D; Kaminski I; Broux V; Puts S; Vanmechelen S; Timmermans A; Noé L; Bulens P; Govers M; Maes A; Mebis J
    Radiother Oncol; 2021 May; 158():268-275. PubMed ID: 33711412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Grade 3/4 dermatitis in head and neck cancer patients treated with concurrent cetuximab and IMRT.
    Studer G; Brown M; Salgueiro EB; Schmückle H; Romancuk N; Winkler G; Lee SJ; Sträuli A; Kissling B; Dummer R; Glanzmann C
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):110-7. PubMed ID: 20732757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural oil-based emulsion containing allantoin versus aqueous cream for managing radiation-induced skin reactions in patients with cancer: a phase 3, double-blind, randomized, controlled trial.
    Chan RJ; Mann J; Tripcony L; Keller J; Cheuk R; Blades R; Keogh S; Poole C; Walsh C
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):756-64. PubMed ID: 25151541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical application of a sandal wood oil and turmeric based cream prevents radiodermatitis in head and neck cancer patients undergoing external beam radiotherapy: a pilot study.
    Palatty PL; Azmidah A; Rao S; Jayachander D; Thilakchand KR; Rai MP; Haniadka R; Simon P; Ravi R; Jimmy R; D'souza PF; Fayad R; Baliga MS
    Br J Radiol; 2014 Jun; 87(1038):20130490. PubMed ID: 24694358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A scoring system predicting acute radiation dermatitis in patients with head and neck cancer treated with intensity-modulated radiotherapy.
    Kawamura M; Yoshimura M; Asada H; Nakamura M; Matsuo Y; Mizowaki T
    Radiat Oncol; 2019 Jan; 14(1):14. PubMed ID: 30665451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of topical timolol for the prevention of radiation-induced dermatitis in breast cancer: a pilot triple-blind, placebo-controlled trial.
    Nabi-Meybodi M; Sahebnasagh A; Hakimi Z; Shabani M; Shakeri AA; Saghafi F
    BMC Cancer; 2022 Oct; 22(1):1079. PubMed ID: 36266613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical steroid versus placebo for the prevention of radiation dermatitis in head and neck cancer patients receiving chemoradiotherapy: the study protocol of J-SUPPORT 1602 (TOPICS study), a randomized double-blinded phase 3 trial.
    Zenda S; Yamaguchi T; Yokota T; Miyaji T; Mashiko T; Tanaka M; Yonemura M; Takeno M; Okano T; Kawasaki T; Nakamori Y; Ishii S; Shimada S; Kanamaru M; Uchitomi Y
    BMC Cancer; 2018 Sep; 18(1):873. PubMed ID: 30189840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase 3 Randomized Trial of Topical Steroid Versus Placebo for Prevention of Radiation Dermatitis in Patients With Head and Neck Cancer Receiving Chemoradiation.
    Yokota T; Zenda S; Ota I; Yamazaki T; Yamaguchi T; Ogawa T; Tachibana H; Toshiyasu T; Homma A; Miyaji T; Mashiko T; Hamauchi S; Tominaga K; Ishii S; Otani Y; Orito N; Uchitomi Y
    Int J Radiat Oncol Biol Phys; 2021 Nov; 111(3):794-803. PubMed ID: 34102298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial Decolonization for Prevention of Radiation Dermatitis: A Randomized Clinical Trial.
    Kost Y; Deutsch A; Mieczkowska K; Nazarian R; Muskat A; Hosgood HD; Lin J; Daily JP; Ohri N; Kabarriti R; Shinoda K; McLellan BN
    JAMA Oncol; 2023 Jul; 9(7):940-945. PubMed ID: 37140904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study assessing the effectiveness of Biafine cream as a prophylactic agent for radiation-induced acute skin toxicity to the breast in women undergoing radiotherapy with concomitant CMF chemotherapy.
    Szumacher E; Wighton A; Franssen E; Chow E; Tsao M; Ackerman I; Andersson L; Kim J; Wojcicka A; Ung Y; Sixel K; Hayter C
    Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):81-6. PubMed ID: 11516855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High rate of severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: results of a survey in EORTC institutes.
    Giro C; Berger B; Bölke E; Ciernik IF; Duprez F; Locati L; Maillard S; Ozsahin M; Pfeffer R; Robertson AG; Langendijk JA; Budach W
    Radiother Oncol; 2009 Feb; 90(2):166-71. PubMed ID: 18977050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypericum perforatum and neem oil for the management of acute skin toxicity in head and neck cancer patients undergoing radiation or chemo-radiation: a single-arm prospective observational study.
    Franco P; Potenza I; Moretto F; Segantin M; Grosso M; Lombardo A; Taricco D; Vallario P; Filippi AR; Rampino M; Ricardi U
    Radiat Oncol; 2014 Dec; 9():297. PubMed ID: 25544371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silver clear nylon dressing is effective in preventing radiation-induced dermatitis in patients with lower gastrointestinal cancer: results from a phase III study.
    Niazi TM; Vuong T; Azoulay L; Marijnen C; Bujko K; Nasr E; Lambert C; Duclos M; Faria S; David M; Cummings B
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e305-10. PubMed ID: 22652101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.